Albiglutide 50 mg

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2

Phase 4

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

CompletedNCT02465515

GlaxoSmithKlineDiabetes Mellitus

Start: 2015-07-01End: 2018-03-14Updated: 2019-03-06

A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects

CompletedNCT02496221

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2015-06-11End: 2015-10-13Updated: 2018-04-05

Related Papers

Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists

Genome Medicine2026-03-29

Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial

Diabetes Obesity and Metabolism2024-02-064 citations

The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study

Trials2021-07-1923 citations

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

2018-10-021188 citations